Declaration of national interest (Argentine Senate)
Project to declare of scientific interest the work of researchers gabriela gutiérrez and agustina aspiroz, who developed a biotechnological enterprise specialized in the study of immunology applied to fertility....
Fertility Technology Breaks Through Gap and Receives Senate Distinction
A new technology created in Argentina by the founding women of Microgenesis succeeded in delivering babies in the United States. The gender vision helped them think differently to identify new causes in women's health that can be treated to restore their fertility.
Nothing better than a woman's vision to bring social impact to science
On the International Day of Women and Girls in Science, we met Gabriela Gutierrez, independent researcher, mother of three, specialist in Reproductive Immunology and member of CONICET since 2005.
From paper to impact: the story of the CONICET researcher who created two biotechs with global impact
Going from writing basic science papers to transforming that knowledge into a value that has the social impact to create a company is not an easy task.
21 Argentine companies to participate in the world's most important biotechnology fair
Chancellor @santiagocafiero and Secretary Todesca Bocco received the companies that will be at the Biotechnology Industry Organization, in the United States, from June 13 to 16.
Gabriela Gutiérrez: “As women, our questions have a different perspective and that allows us to do new science”
She is a doctor in reproductive immunology and an independent researcher at Conicet, and the only Argentine woman who has been able to create two biotechs in the fertility area.
Spotify: Fertility & Gut Health w/Microgenesis
Constipation, diarrhea, bloat and more - your gut health and fertility! Major tie-ins between gut health or the lack thereof and infertility. This is an important dialogue addressing how Microgenesis solves the problem of gut dysbiosis which in turn restores fertility potential!
Female fertility: Argentine scientists create a startup that could be a new unicorn
They launched the drug-free treatment in the United States; it is based on a self-administered kit and nutritional changes; an accelerator is involved in the project.